Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−19.90 M USD
11.76 M USD
28.66 M
About CapsoVision, Inc.
Sector
Industry
CEO
Kang-Huai Wang
Website
Headquarters
Saratoga
Founded
2005
ISIN
US1409351079
FIGI
BBG00KHZ9QJ2
CapsoVision, Inc. operates as a commercial-stage medical technology company. It engages in the development of imaging and artificial intelligence (AI) technologies that are deployed for endoscopy solutions to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. The firm developed capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s disease. The company was founded by Kang-Huai Wang on August 1, 2005 and is headquartered in Saratoga, CA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
The current price of CV is 4.71 USD — it has increased by 2.95% in the past 24 hours. Watch CapsoVision, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CapsoVision, Inc. stocks are traded under the ticker CV.
CV stock has risen by 2.84% compared to the previous week, the month change is a 27.64% rise, over the last year CapsoVision, Inc. has showed a −5.80% decrease.
We've gathered analysts' opinions on CapsoVision, Inc. future price: according to them, CV price has a max estimate of 5.00 USD and a min estimate of 5.00 USD. Watch CV chart and read a more detailed CapsoVision, Inc. stock forecast: see what analysts think of CapsoVision, Inc. and suggest that you do with its stocks.
CV stock is 6.44% volatile and has beta coefficient of 1.65. Track CapsoVision, Inc. stock price on the chart and check out the list of the most volatile stocks — is CapsoVision, Inc. there?
Yes, you can track CapsoVision, Inc. financials in yearly and quarterly reports right on TradingView.
CapsoVision, Inc. is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
CV earnings for the last quarter are −2.02 USD per share, whereas the estimation was −0.11 USD resulting in a −1.74 K% surprise. The estimated earnings for the next quarter are −0.11 USD per share. See more details about CapsoVision, Inc. earnings.
CapsoVision, Inc. revenue for the last quarter amounts to 3.31 M USD, despite the estimated figure of 3.25 M USD. In the next quarter, revenue is expected to reach 3.67 M USD.
CV net income for the last quarter is −4.63 M USD, while the quarter before that showed −5.38 M USD of net income which accounts for 13.95% change. Track more CapsoVision, Inc. financial stats to get the full picture.
No, CV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CapsoVision, Inc. stock right from TradingView charts — choose your broker and connect to your account.